Both GRB7 and MED24 have been found to be part of the smallest region of amplification (SRA), which extends from 34.73 to 35.48 Mb in HER2-amplified tumours but does not include TOP2A (Arriola et al, 2008). The gene discussed is ERBB2; the disease is neoplasm.